Tsutomu Yamazaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tsutomu Yamazaki has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Reiko Yamaura
IQVIA Solutions Japan G.K., 4-10-18 Takanawa Keikyu Dai-Ichi Building, Minato-ku, Tokyo, 108-0074, Japan
3 shared publications - Akinori Nakata
Department of Preventive Medicine and Community Health, University of Occupational and Environmental Health Japan, Kitakyushu, Japan
2 shared publications - Harumi Gomi
Graduate School of Medicine, International University of Health and Welfare, Tokyo 107-8402, Japan
2 shared publications Hideko Kasahara
2 shared publicationsKiyohide Fushimi
Institute of Science Tokyo
2 shared publicationsKiyoshi Seshimo
Kastec, Kyushu University, Kasuga-shi, Fukuoka 816-8580, Japan
2 shared publications
Latest Publications
- Open Access
- 23 July 2026
- Published by Springer Nature in Discover Social Science and Health
- Vol. 6 (1)
A nationwide ecological analysis of municipal factors affecting breast cancer screening participation during the COVID-19 pandemic in Japan
- 23 July 2026
- Published by Springer Nature in Discover Social Science and Health
- Vol. 6 (1)
Open AccessA nationwide ecological analysis of municipal factors affecting breast cancer screening participation during the COVID-19 pandemic in Japan
- Open Access
- 1 May 2026
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 18 (5) , 292-300
Prescribing of GLP-1 and GIP/GLP-1 Receptor Agonists and Other Glucose-Lowering Drugs Requiring Special Caution in Elderly Japanese People With Type 2 Diabetes: A Preliminary Report
Background: Adverse drug events are more common in elderly people, prompting the Japan Geriatrics Society to update its “Guidelines for Safe Pharmacotherapy in the Elderly” in 2025. In this revision, glucagon-like peptide-1 receptor agonist (GLP-1RA) and glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist (GIP/GLP-1RA) were newly added to the list of drugs requiring special caution. This study aimed to descriptively investigate real-world prescribing patterns of GLP-1RAs and their concomitant use with other glucose-lowering drugs (GLDs) requiring special caution among elderly people with type 2 diabetes (T2D). Methods: This single-center, retrospective, cross-sectional, exploratory descriptive study included outpatients aged ≥ 65 years with T2D who received antihyperglycemic therapy between September and December 2025. Clinical characteristics, laboratory data, and prescription records were extracted from electronic medical records. Descriptive analyses were conducted stratified by GLP-1RA use (users vs. non-users) and by age categories (65 to < 75 years and ≥ 75 years). Results: Among 214 eligible people with T2D, 50 (23.4%) were prescribed GLP-1RAs. Among GLP-1RA users, 63.0% were classified as having obesity, and the mean number of concomitant GLDs was 3.2 ± 0.8. GLP-1RAs were often prescribed concomitantly with other GLDs requiring special caution in elderly people, including metformin, sodium-glucose cotransporter 2 inhibitor (SGLT2i), sulfonylureas, and insulin. In age-stratified analyses, oral semaglutide and dulaglutide were the most prescribed GLP-1RAs among people aged ≥ 75 years. Conclusions: GLP-1RAs were prescribed to approximately one quarter of elderly people with T2D and were most commonly used in people with obesity and more complex glucose-lowering regimens. Their frequent concomitant use with other drugs requiring special caution underscores the complexity of pharmacological management in elderly people.
- 1 May 2026
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 18 (5) , 292-300
Open AccessPrescribing of GLP-1 and GIP/GLP-1 Receptor Agonists and Other Glucose-Lowering Drugs Requiring Special Caution in Elderly Japanese People With Type 2 Diabetes: A Preliminary Report
Background: Adverse drug events are more common in elderly people, prompting the Japan Geriatrics Society to update its “Guidelines for Safe Pharmacotherapy in the Elderly” in 2025. In this revision, glucagon-like peptide-1 receptor agonist (GLP-1RA) and glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist (GIP/GLP-1RA) were newly added to the list of drugs requiring special caution. This study aimed to descriptively investigate real-world prescribing patterns of GLP-1RAs and their concomitant use with other glucose-lowering drugs (GLDs) requiring special caution among elderly people with type 2 diabetes (T2D). Methods: This single-center, retrospective, cross-sectional, exploratory descriptive study included outpatients aged ≥ 65 years with T2D who received antihyperglycemic therapy between September and December 2025. Clinical characteristics, laboratory data, and prescription records were extracted from electronic medical records. Descriptive analyses were conducted stratified by GLP-1RA use (users vs. non-users) and by age categories (65 to < 75 years and ≥ 75 years). Results: Among 214 eligible people with T2D, 50 (23.4%) were prescribed GLP-1RAs. Among GLP-1RA users, 63.0% were classified as having obesity, and the mean number of concomitant GLDs was 3.2 ± 0.8. GLP-1RAs were often prescribed concomitantly with other GLDs requiring special caution in elderly people, including metformin, sodium-glucose cotransporter 2 inhibitor (SGLT2i), sulfonylureas, and insulin. In age-stratified analyses, oral semaglutide and dulaglutide were the most prescribed GLP-1RAs among people aged ≥ 75 years. Conclusions: GLP-1RAs were prescribed to approximately one quarter of elderly people with T2D and were most commonly used in people with obesity and more complex glucose-lowering regimens. Their frequent concomitant use with other drugs requiring special caution underscores the complexity of pharmacological management in elderly people.
- Open Access
- 1 May 2026
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 22, 1-14
Longitudinal Associations Between Metabolic Risk Burden and the Cardio–Ankle Vascular Index (CAVI) in Japan Using Health-Check Cohort
The cardio–ankle vascular index (CAVI) is a blood pressure-independent indicator of arterial stiffness. Although CAVI is associated with metabolic risk factors, longitudinal evidence clarifying their relative impact remains limited. This study aimed to examine longitudinal associations between metabolic abnormalities and CAVI in a Japanese health check-up population, focusing on MetS components and waist circumference (WC) status. A total of 13,724 adults (7060 men and 6664 women) who underwent annual health check-ups at the International University of Health and Welfare Narita Hospital between 2020 and 2024 were included. Linear mixed-effects models were used to evaluate longitudinal changes in CAVI according to MetS components (blood pressure, glucose, lipids, and WC). Secondary analyses examined CAVI changes by MetS status, WC strata (WC (+)/WC (-)), metabolic risk count (0–3) and sex. Older age and male sex were independently associated with higher CAVI. Blood pressure and glucose abnormalities showed the strongest associations with elevated CAVI, whereas lipid risk had a modest effect and WC was inversely associated with CAVI. CAVI increased annually overall, but increased more slowly among participants with blood pressure risk. Time interactions for glucose, lipid and WC risk were not significant. MetS was associated with higher baseline CAVI, but longitudinal time interactions did not differ significantly by MetS status. In WC-stratified analyses, baseline CAVI increased stepwise with accumulation of metabolic risk factors in both WC (+) and WC (−) groups, including a substantial WC (-)-subgroup—particularly women—with multiple metabolic risks and elevated CAVI. Longitudinal follow-up revealed modest CAVI progression with attenuated slopes among participants with high-baseline CAVI, indicating that baseline CAVI captures cumulative vascular injury rather than accelerated short-term change. CAVI may complement WC-centered screening by identifying non-obese individuals—especially women—with elevated longitudinal vascular risk.
- 1 May 2026
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 22, 1-14
Open AccessLongitudinal Associations Between Metabolic Risk Burden and the Cardio–Ankle Vascular Index (CAVI) in Japan Using Health-Check Cohort
The cardio–ankle vascular index (CAVI) is a blood pressure-independent indicator of arterial stiffness. Although CAVI is associated with metabolic risk factors, longitudinal evidence clarifying their relative impact remains limited. This study aimed to examine longitudinal associations between metabolic abnormalities and CAVI in a Japanese health check-up population, focusing on MetS components and waist circumference (WC) status. A total of 13,724 adults (7060 men and 6664 women) who underwent annual health check-ups at the International University of Health and Welfare Narita Hospital between 2020 and 2024 were included. Linear mixed-effects models were used to evaluate longitudinal changes in CAVI according to MetS components (blood pressure, glucose, lipids, and WC). Secondary analyses examined CAVI changes by MetS status, WC strata (WC (+)/WC (-)), metabolic risk count (0–3) and sex. Older age and male sex were independently associated with higher CAVI. Blood pressure and glucose abnormalities showed the strongest associations with elevated CAVI, whereas lipid risk had a modest effect and WC was inversely associated with CAVI. CAVI increased annually overall, but increased more slowly among participants with blood pressure risk. Time interactions for glucose, lipid and WC risk were not significant. MetS was associated with higher baseline CAVI, but longitudinal time interactions did not differ significantly by MetS status. In WC-stratified analyses, baseline CAVI increased stepwise with accumulation of metabolic risk factors in both WC (+) and WC (−) groups, including a substantial WC (-)-subgroup—particularly women—with multiple metabolic risks and elevated CAVI. Longitudinal follow-up revealed modest CAVI progression with attenuated slopes among participants with high-baseline CAVI, indicating that baseline CAVI captures cumulative vascular injury rather than accelerated short-term change. CAVI may complement WC-centered screening by identifying non-obese individuals—especially women—with elevated longitudinal vascular risk.
- Open Access
- 24 March 2026
- Published by Wiley in Pediatric Anesthesia
- Vol. 36 (6) , 703-713
Impact of Priming Volume Reduction on Hematocrit Retention in Pediatric Cardiopulmonary Bypass: A Retrospective Analysis
Background: Retrograde autologous priming and venous antegrade priming replace the cardiopulmonary bypass circuit crystalloid with patient blood to mitigate hemodilution. However, their effectiveness in pediatric patients, particularly when analyzed as continuous variables, remains unclear. Aims: We aimed to evaluate the effects of autologous priming techniques on blood conservation and patient safety during pediatric cardiac surgery. Methods: This retrospective cohort study included 191 patients (age 0–14 years; weight > 6 kg) who underwent repair of ventricular and/or atrial septal defects. The primary endpoint was the correlation between the priming volume reduction rate (proportion of priming solution replaced) and the hematocrit retention ratio (hematocrit immediately after cardiopulmonary bypass initiation divided by pre‐bypass hematocrit). Secondary outcomes, including transfusion rates, regional cerebral oxygen saturation, and lactate levels, were compared between a retrograde autologous priming group ( n = 144) and a control group ( n = 47). All patients underwent venous antegrade priming. Results: The priming volume reduction rate correlated positively with the hematocrit retention ratio (Spearman's ρ = 0.545, p < 0.001). Multiple regression confirmed this independent association: a 0.1 increase in the priming volume reduction rate corresponded to a 0.5% absolute increase in hematocrit at bypass initiation. The retrograde autologous priming group had a significantly higher transfusion‐free surgery rate (93.1% vs. 76.6%; relative risk ratio 1.22; p = 0.005). Regarding safety and the postoperative course, no significant intergroup differences were found in trends in regional cerebral oxygen saturation (Time × retrograde autologous priming interaction) or in lactate levels. Similarly, intensive care unit and hospital lengths of stay did not differ significantly between groups. Safety analyses suggested no evidence of cerebral perfusion suppression during retrograde autologous priming. Conclusion: These findings suggest that even partial retrograde autologous priming is effective to mitigate hemodilution and is independently associated with improved hematocrit retention and a significant reduction in transfusion risk after initiation of cardiopulmonary bypass in pediatric patients. Trial Registration: This study was registered with the UMIN Clinical Trials Registry, Japan, prior to commencement (Trial ID: R000067879)
- 24 March 2026
- Published by Wiley in Pediatric Anesthesia
- Vol. 36 (6) , 703-713
Open AccessImpact of Priming Volume Reduction on Hematocrit Retention in Pediatric Cardiopulmonary Bypass: A Retrospective Analysis
Background: Retrograde autologous priming and venous antegrade priming replace the cardiopulmonary bypass circuit crystalloid with patient blood to mitigate hemodilution. However, their effectiveness in pediatric patients, particularly when analyzed as continuous variables, remains unclear. Aims: We aimed to evaluate the effects of autologous priming techniques on blood conservation and patient safety during pediatric cardiac surgery. Methods: This retrospective cohort study included 191 patients (age 0–14 years; weight > 6 kg) who underwent repair of ventricular and/or atrial septal defects. The primary endpoint was the correlation between the priming volume reduction rate (proportion of priming solution replaced) and the hematocrit retention ratio (hematocrit immediately after cardiopulmonary bypass initiation divided by pre‐bypass hematocrit). Secondary outcomes, including transfusion rates, regional cerebral oxygen saturation, and lactate levels, were compared between a retrograde autologous priming group ( n = 144) and a control group ( n = 47). All patients underwent venous antegrade priming. Results: The priming volume reduction rate correlated positively with the hematocrit retention ratio (Spearman's ρ = 0.545, p < 0.001). Multiple regression confirmed this independent association: a 0.1 increase in the priming volume reduction rate corresponded to a 0.5% absolute increase in hematocrit at bypass initiation. The retrograde autologous priming group had a significantly higher transfusion‐free surgery rate (93.1% vs. 76.6%; relative risk ratio 1.22; p = 0.005). Regarding safety and the postoperative course, no significant intergroup differences were found in trends in regional cerebral oxygen saturation (Time × retrograde autologous priming interaction) or in lactate levels. Similarly, intensive care unit and hospital lengths of stay did not differ significantly between groups. Safety analyses suggested no evidence of cerebral perfusion suppression during retrograde autologous priming. Conclusion: These findings suggest that even partial retrograde autologous priming is effective to mitigate hemodilution and is independently associated with improved hematocrit retention and a significant reduction in transfusion risk after initiation of cardiopulmonary bypass in pediatric patients. Trial Registration: This study was registered with the UMIN Clinical Trials Registry, Japan, prior to commencement (Trial ID: R000067879)
- Open Access
- 4 March 2025
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 11 (1) , e64020
Breast Cancer Screening Participation and Internet Search Activity in a Japanese Population: Decade-Long Time-Series Study
Background: Breast cancer is a major health concern in various countries. Routine mammography screening has been shown to reduce breast cancer mortality, and Japan has set national targets to improve screening participation and increase public attention. However, collecting nationwide data on public attention and activity is not easy. Google Trends can reveal changes in societal interest, yet there are no reports on the relationship between internet search volume and nationwide participation rates in Japan. Objective: This study aims to reveal and discuss the relationship between public awareness and actual behavior in breast cancer screening by examining trends in internet search volume for the keyword “breast cancer screening” and participation rates over a decade-long period. Methods: This time-series study evaluated the association between internet search volume and breast cancer screening participation behavior among women aged 60‐69 years in Japan from 2009 to 2019. Relative search volume (RSV) data for the search term “breast cancer screening (nyuugan-kenshin)” were extracted from Google Trends as internet search volume. Breast cancer screening and further assessment participation rates were based on government municipal screening data. Joinpoint regression analyses were conducted with weighted BIC to evaluate the time trends. An ethics review was not required because all data were open. Results: The RSV for “breast cancer screening (nyuugan-kenshin)” peaked in June 2017 (100) and showed clear spikes in June 2016 (94), September (69), and October (77) 2015. No RSVs above 60 were observed except around these three specific periods, and the average RSV for the entire period was 30.7 (SD 16.2). Two statistically significant joinpoints were detected, rising in December 2013 and falling in June 2017. Screening participation rates showed a temporary increase in 2015 in a slowly decreasing trend, and no joinpoints were detected. Further assessment participation rates showed a temporary spike in 2015 in the middle of an increasing trend, with a statistically significant point of slowing increase detected in 2015. Post hoc manual searches revealed that Japanese celebrities’ breast cancer diagnoses were announced on the relevant dates, and many Japanese media reports were found. Conclusions: This study found a notable association between internet search activity and celebrity cancer media reports and a temporal association with screening participation in breast cancer screening in Japan. Celebrity cancer media reports triggered internet searches for cancer screening, but this did not lead to long-term changes in screening participation behavior. This finding suggests what information needs to be provided to citizens to encourage participation in screening.
- 4 March 2025
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 11 (1) , e64020
Open AccessBreast Cancer Screening Participation and Internet Search Activity in a Japanese Population: Decade-Long Time-Series Study
Background: Breast cancer is a major health concern in various countries. Routine mammography screening has been shown to reduce breast cancer mortality, and Japan has set national targets to improve screening participation and increase public attention. However, collecting nationwide data on public attention and activity is not easy. Google Trends can reveal changes in societal interest, yet there are no reports on the relationship between internet search volume and nationwide participation rates in Japan. Objective: This study aims to reveal and discuss the relationship between public awareness and actual behavior in breast cancer screening by examining trends in internet search volume for the keyword “breast cancer screening” and participation rates over a decade-long period. Methods: This time-series study evaluated the association between internet search volume and breast cancer screening participation behavior among women aged 60‐69 years in Japan from 2009 to 2019. Relative search volume (RSV) data for the search term “breast cancer screening (nyuugan-kenshin)” were extracted from Google Trends as internet search volume. Breast cancer screening and further assessment participation rates were based on government municipal screening data. Joinpoint regression analyses were conducted with weighted BIC to evaluate the time trends. An ethics review was not required because all data were open. Results: The RSV for “breast cancer screening (nyuugan-kenshin)” peaked in June 2017 (100) and showed clear spikes in June 2016 (94), September (69), and October (77) 2015. No RSVs above 60 were observed except around these three specific periods, and the average RSV for the entire period was 30.7 (SD 16.2). Two statistically significant joinpoints were detected, rising in December 2013 and falling in June 2017. Screening participation rates showed a temporary increase in 2015 in a slowly decreasing trend, and no joinpoints were detected. Further assessment participation rates showed a temporary spike in 2015 in the middle of an increasing trend, with a statistically significant point of slowing increase detected in 2015. Post hoc manual searches revealed that Japanese celebrities’ breast cancer diagnoses were announced on the relevant dates, and many Japanese media reports were found. Conclusions: This study found a notable association between internet search activity and celebrity cancer media reports and a temporal association with screening participation in breast cancer screening in Japan. Celebrity cancer media reports triggered internet searches for cancer screening, but this did not lead to long-term changes in screening participation behavior. This finding suggests what information needs to be provided to citizens to encourage participation in screening.
- 28 February 2025
- Published by Taylor & Francis in Future Oncology
- Vol. 21 (9) , 1101-1111
Systemic treatment patterns and adherence to guidelines in Japanese patients with metastatic non-small cell lung cancer
Non-small-cell-lung cancer (NSCLC) medication use and guideline adherence remain unclear. We investigated treatment patterns and adherence among Japanese patients with NSCLC. We analyzed treatment patterns and guideline adherence by age and histology in ≥ 20-year-olds with stage IV NSCLC treated between 2016-2018 using diagnostic procedure combination data. Logistic regression analysis evaluated the impact of various factors on guideline adherence. We included 9,722 patients. In < 75-year-olds with nonsquamous NSCLC, first-to third-line treatments comprised 31.8% platinum combination therapy, 26.3% immune checkpoint inhibitors, and 62.5% cytotoxic chemotherapy. In ≥ 75-year-olds, first-line and second-line molecular targeted therapies represented 46.6% and 35.6%, whereas third-line cytotoxic chemotherapy represented 42.3%. In squamous NSCLC, first-line platinum combination therapy was predominant (69.7% and 47.7% for < 75-and ≥75-year-olds). The most common second-line and third-line therapies were immune checkpoint inhibitors (48.6% and 50.8% for < 75-and ≥75-year-olds) and cytotoxic chemotherapy (62.5% and 55.2% for < 75-and ≥75-year-olds), respectively. The highest guideline adherence (90%) was in < 75-year-olds with squamous NSCLC. Age, histology, activities of daily living, and cumulative hospitalizations over the past 18 months influenced treatment adherence. New NSCLC drug introduction increased regardless of age, suggesting prognosis improvement. More efficient drug application and broader guideline dissemination are required.
- 28 February 2025
- Published by Taylor & Francis in Future Oncology
- Vol. 21 (9) , 1101-1111
Systemic treatment patterns and adherence to guidelines in Japanese patients with metastatic non-small cell lung cancer
Non-small-cell-lung cancer (NSCLC) medication use and guideline adherence remain unclear. We investigated treatment patterns and adherence among Japanese patients with NSCLC. We analyzed treatment patterns and guideline adherence by age and histology in ≥ 20-year-olds with stage IV NSCLC treated between 2016-2018 using diagnostic procedure combination data. Logistic regression analysis evaluated the impact of various factors on guideline adherence. We included 9,722 patients. In < 75-year-olds with nonsquamous NSCLC, first-to third-line treatments comprised 31.8% platinum combination therapy, 26.3% immune checkpoint inhibitors, and 62.5% cytotoxic chemotherapy. In ≥ 75-year-olds, first-line and second-line molecular targeted therapies represented 46.6% and 35.6%, whereas third-line cytotoxic chemotherapy represented 42.3%. In squamous NSCLC, first-line platinum combination therapy was predominant (69.7% and 47.7% for < 75-and ≥75-year-olds). The most common second-line and third-line therapies were immune checkpoint inhibitors (48.6% and 50.8% for < 75-and ≥75-year-olds) and cytotoxic chemotherapy (62.5% and 55.2% for < 75-and ≥75-year-olds), respectively. The highest guideline adherence (90%) was in < 75-year-olds with squamous NSCLC. Age, histology, activities of daily living, and cumulative hospitalizations over the past 18 months influenced treatment adherence. New NSCLC drug introduction increased regardless of age, suggesting prognosis improvement. More efficient drug application and broader guideline dissemination are required.
- Open Access
- 21 January 2025
- Published by Elsevier in Infection Prevention in Practice
- Vol. 7 (1) , 100440
Clinical and economic impact of ventilator-associated pneumonia in intensive care units in Japan
- 21 January 2025
- Published by Elsevier in Infection Prevention in Practice
- Vol. 7 (1) , 100440
Open AccessClinical and economic impact of ventilator-associated pneumonia in intensive care units in Japan
- Open Access
- 30 September 2023
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 7 (12) , e10820
The Association between Sleep and Bone Mineral Density: Cross‐Sectional Study Using Health Check‐up Data in a Local Hospital in Japan
This study aimed to investigate the association between daily sleep duration of p = 0.004). No association between insomnia and BMD was found. Overall, a daily sleep duration of JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
- 30 September 2023
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 7 (12) , e10820
Open AccessThe Association between Sleep and Bone Mineral Density: Cross‐Sectional Study Using Health Check‐up Data in a Local Hospital in Japan
This study aimed to investigate the association between daily sleep duration of p = 0.004). No association between insomnia and BMD was found. Overall, a daily sleep duration of JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
- Top Cited PapersOpen Access
- 30 August 2023
- Published by Springer Nature in Nature
- Vol. 621 (7978) , 389-395
Gut microbial carbohydrate metabolism contributes to insulin resistance
Insulin resistance is the primary pathophysiology underlying metabolic syndrome and type 2 diabetes1,2. Previous metagenomic studies have described the characteristics of gut microbiota and their roles in metabolizing major nutrients in insulin resistance3–9. In particular, carbohydrate metabolism of commensals has been proposed to contribute up to 10% of the host’s overall energy extraction10, thereby playing a role in the pathogenesis of obesity and prediabetes3,4,6. Nevertheless, the underlying mechanism remains unclear. Here we investigate this relationship using a comprehensive multi-omics strategy in humans. We combine unbiased faecal metabolomics with metagenomics, host metabolomics and transcriptomics data to profile the involvement of the microbiome in insulin resistance. These data reveal that faecal carbohydrates, particularly host-accessible monosaccharides, are increased in individuals with insulin resistance and are associated with microbial carbohydrate metabolisms and host inflammatory cytokines. We identify gut bacteria associated with insulin resistance and insulin sensitivity that show a distinct pattern of carbohydrate metabolism, and demonstrate that insulin-sensitivity-associated bacteria ameliorate host phenotypes of insulin resistance in a mouse model. Our study, which provides a comprehensive view of the host–microorganism relationships in insulin resistance, reveals the impact of carbohydrate metabolism by microbiota, suggesting a potential therapeutic target for ameliorating insulin resistance.
- 30 August 2023
- Published by Springer Nature in Nature
- Vol. 621 (7978) , 389-395
Top Cited PapersOpen AccessGut microbial carbohydrate metabolism contributes to insulin resistance
Insulin resistance is the primary pathophysiology underlying metabolic syndrome and type 2 diabetes1,2. Previous metagenomic studies have described the characteristics of gut microbiota and their roles in metabolizing major nutrients in insulin resistance3–9. In particular, carbohydrate metabolism of commensals has been proposed to contribute up to 10% of the host’s overall energy extraction10, thereby playing a role in the pathogenesis of obesity and prediabetes3,4,6. Nevertheless, the underlying mechanism remains unclear. Here we investigate this relationship using a comprehensive multi-omics strategy in humans. We combine unbiased faecal metabolomics with metagenomics, host metabolomics and transcriptomics data to profile the involvement of the microbiome in insulin resistance. These data reveal that faecal carbohydrates, particularly host-accessible monosaccharides, are increased in individuals with insulin resistance and are associated with microbial carbohydrate metabolisms and host inflammatory cytokines. We identify gut bacteria associated with insulin resistance and insulin sensitivity that show a distinct pattern of carbohydrate metabolism, and demonstrate that insulin-sensitivity-associated bacteria ameliorate host phenotypes of insulin resistance in a mouse model. Our study, which provides a comprehensive view of the host–microorganism relationships in insulin resistance, reveals the impact of carbohydrate metabolism by microbiota, suggesting a potential therapeutic target for ameliorating insulin resistance.
- Open Access
- 21 November 2022
- Published by MDPI AG in Nursing Reports
- Vol. 12 (4) , 894-903
Perspectives on Collaboration between Physicians and Nurse Practitioners in Japan: A Cross-Sectional Study
Background: Nurse practitioners (NPs) are known as effective healthcare providers worldwide. In Japan, nurse practitioner adoption is considered to be in a shaky period. Although nurse practitioners were introduced approximately 10 years ago at the initiative of educational institutions in Japan, the full extent of this trend is not known. Therefore, we have clarified the whole picture of nurse practitioners from two directions: the perception of nurse practitioners in Japan and the perception of physicians who work with nurse practitioners. This will inform discussions regarding the recruitment of nurse practitioners at the national level in Japan. Methods: From 18 June to 24 July 2021, we administered a nationwide cross-sectional survey of NPs and physicians working in the same clinical settings as NPs in Japan. The domains of the survey included “scope and content of work”, “perceptions of NPs’ clinical practice”, and “individual clinical practice characteristics”. The survey was distributed and collected digitally. Results: The total number of respondents to the survey was 281, including 169 NPs and 112 physicians; the percentage of NPs who responded was 50.5%. The number of valid responses was 164 NPs and 111 physicians, for a total of 275 respondents. Approximately 60% of NPs are concentrated in Tokyo, the capital of Japan, and the three prefectures adjacent to Tokyo. They also worked fewer hours per week, cared for fewer patients per day, and earned less money than physicians. More physicians than NPs indicated that “more NPs would improve the quality of care”. A total of 90.1% of physicians and 82.3% of NPs agreed that “Nurse practitioners should practice to the full extent of their education and training,” and 73.9% of physicians and 81.7% of NPs agreed that “Nurse practitioners’ scope of practice should be uniformly defined at a national level”. Conclusions: This study clarified the present working conditions of NPs from NPs’ and physicians’ perspectives in Japanese contexts. Japanese NPs may be able to work effectively in collaboration with physicians. Therefore, the implementation of NPs in Japanese medical conditions should be discussed further for better healthcare.
- 21 November 2022
- Published by MDPI AG in Nursing Reports
- Vol. 12 (4) , 894-903
Open AccessPerspectives on Collaboration between Physicians and Nurse Practitioners in Japan: A Cross-Sectional Study
Background: Nurse practitioners (NPs) are known as effective healthcare providers worldwide. In Japan, nurse practitioner adoption is considered to be in a shaky period. Although nurse practitioners were introduced approximately 10 years ago at the initiative of educational institutions in Japan, the full extent of this trend is not known. Therefore, we have clarified the whole picture of nurse practitioners from two directions: the perception of nurse practitioners in Japan and the perception of physicians who work with nurse practitioners. This will inform discussions regarding the recruitment of nurse practitioners at the national level in Japan. Methods: From 18 June to 24 July 2021, we administered a nationwide cross-sectional survey of NPs and physicians working in the same clinical settings as NPs in Japan. The domains of the survey included “scope and content of work”, “perceptions of NPs’ clinical practice”, and “individual clinical practice characteristics”. The survey was distributed and collected digitally. Results: The total number of respondents to the survey was 281, including 169 NPs and 112 physicians; the percentage of NPs who responded was 50.5%. The number of valid responses was 164 NPs and 111 physicians, for a total of 275 respondents. Approximately 60% of NPs are concentrated in Tokyo, the capital of Japan, and the three prefectures adjacent to Tokyo. They also worked fewer hours per week, cared for fewer patients per day, and earned less money than physicians. More physicians than NPs indicated that “more NPs would improve the quality of care”. A total of 90.1% of physicians and 82.3% of NPs agreed that “Nurse practitioners should practice to the full extent of their education and training,” and 73.9% of physicians and 81.7% of NPs agreed that “Nurse practitioners’ scope of practice should be uniformly defined at a national level”. Conclusions: This study clarified the present working conditions of NPs from NPs’ and physicians’ perspectives in Japanese contexts. Japanese NPs may be able to work effectively in collaboration with physicians. Therefore, the implementation of NPs in Japanese medical conditions should be discussed further for better healthcare.